Therapeutic HPV Vaccination: Ready for Primetime? (3549)
Cervical neoplasia is the ideal disease process for immunotherapy given the majority of cases are associated with HPV. With its ubiquitous presence, researchers have a common target to create immunotherapeutic approaches. This presentation will discuss the natural history of cervical neoplasia, the rationale and unmet clinical need for non-surgical treatment options, and known limitations and concerns associated with therapeutic HPV vaccination. Finally, the presentation will review recent clinical trial data and discuss whether we really need a non-surgical option.